Cognitive dysfunction with tolterodine use

Stefano Salvatore, Maurizio Serati, Linda Cardozo, Stefano Uccella, Pierfrancesco Bolis

Research output: Contribution to journalArticlepeer-review


This is the first case of a 65 year old healthy woman developing de novo mental confusion during treatment with 2 mg tolterodine twice daily. It is a rare complication of therapy for overactive bladder and resolved when dosage was reduced to 1 mg, although overactive bladder symptoms were still controlled.

Original languageEnglish
JournalAmerican Journal of Obstetrics and Gynecology
Issue number2
Publication statusPublished - Aug 2007


  • cognitive dysfunction
  • neurological impairment
  • overactive bladder treatment
  • tolterodine

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynaecology

Fingerprint Dive into the research topics of 'Cognitive dysfunction with tolterodine use'. Together they form a unique fingerprint.

Cite this